Orchard Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Orchard Therapeutics has a total shareholder equity of $80.3M and total debt of $25.6M, which brings its debt-to-equity ratio to 31.9%. Its total assets and total liabilities are $202.3M and $122.0M respectively.
Key information
31.9%
Debt to equity ratio
US$25.59m
Debt
Interest coverage ratio | n/a |
Cash | US$125.41m |
Equity | US$80.26m |
Total liabilities | US$122.01m |
Total assets | US$202.27m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OT10's short term assets ($153.9M) exceed its short term liabilities ($49.4M).
Long Term Liabilities: OT10's short term assets ($153.9M) exceed its long term liabilities ($72.6M).
Debt to Equity History and Analysis
Debt Level: OT10 has more cash than its total debt.
Reducing Debt: OT10's debt to equity ratio has increased from 0% to 31.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OT10 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: OT10 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 1.6% each year